mesalamine


Also found in: Thesaurus, Medical, Legal, Financial, Encyclopedia, Wikipedia.

me·sal·a·mine

 (mə-săl′ə-mēn′)
n.
A salicylate drug derived from sulfasalazine, C7H7NO3, used primarily to treat inflammatory bowel disease.

Translations

mesalamine

(USAN), mesalazine (INN) n mesalamina, mesalazina (INN)
References in periodicals archive ?
('Teva') regarding APRISO (mesalamine) extended-release capsules 0.375g.
M2 PHARMA-June 24, 2019-Rising Pharmaceuticals Launches Mesalamine Suppository
* Aminosalicylates: Sulfasalazine (Azulfidine), olsalazine (Dipentum), mesalamine (Apriso, Asacol), balsalazide (Colazol)
M2 EQUITYBITES-December 18, 2018-Mylan NV unveils Mesalamine Delayed-Release Tablets USP in 1.2 g for management of ulcerative colitis in US patients
Global Banking News-December 18, 2018-Mylan NV unveils Mesalamine Delayed-Release Tablets USP in 1.2 g for management of ulcerative colitis in US patients
launch of Mesalamine Rectal Suppository, 1000 mg, the first generic version of Allergan's (AGN) Canasa Rectal Suppository, 1000 mg.
Last month, Zydus announced the launch of its ANDA for mesalamine 800 mg delayed-release tablets.
Steroids, mesalamine, and azathioprine were given to the patient.
Enormous efforts have been made to find an effective therapy for IBD although current drugs including sulfasalazine, mesalamine, and corticosteroids taken alone or in combination contribute to decelerating disease progression [3].
Patients with UC are usually prescribed mesalamine which can also cause cardiac complications.
[11] Mesalamine (5-aminosalicylic acid) enema 1 g/day was added to the existing SASP therapy.